doi:10.2460/javma.20.08.0462
Medications: Sodium-glucose cotransporter-2 inhibitors 12 , DHEA 13 , dopamine agonists 14 and verapamil 15 can increase IGF-1 levels, while clomiphene citrate 16 , atorvastatin 17 and long-term somatostatin analogues can reduce IGF-1 18
Key Scientific Attributes High-purity Cagrilintide (98% by HPLC/MS, acetate salt form) Verified 37-amino-acid sequence with C14 fatty acid lipidation at Lys Lyophilized formulation for maximum long-term stability Full Certificate of Analysis (COA) with HPLC, MS, lipidation verification, and receptor-binding data Manufactured in GMP-aligned, ISO-compliant facilities Suitable for amylin receptor and energy homeostasis research Research-Referenced Attributes (Based on published preclinical literature
The early results are encouraging
M.RheeJ.JgerS.et al (2006)
Lower doses may not achieve meaningful weight loss, and self-dosing can lead to harm. While compounding pharmacies can be legitimate and useful in specific cases, Whyte recommends using caution
